WS21.9 Lung clearance index as a clinical trial outcome measure: Establishing the CTN LCI core facility
نویسندگان
چکیده
منابع مشابه
Is Lung Clearance Index (LCI) Affected by the Severity of Lung Disease in CF?
Background: LCI has been proven an effective tool in the detection of lung disease in CF. Objectives: a) To assess the correlation of ventilation inhomogeneity indices with structural damages of the lung, among different groups of disease severity and b) To compare the associations among MBW parameters with spirometry and CT. Method: Forty-four children and adolescents with CF participated in t...
متن کاملEstablishing a Successful Bioinformatics Core Facility Team
There are many issues to consider when establishing and building a Bioinformatics Core Facility. Mission, funding, scope of projects, organizational context, infrastructure, software support, and training are among the many to consider. One of the most important and arguably the most critical to success is building the team to execute the mission of the group. We devote this Perspective to our ...
متن کاملEstimating a Preference-Based Index from the Clinical Outcomes in Routine Evaluation–Outcome Measure (CORE-OM)
BACKGROUND The Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is used to evaluate the effectiveness of psychological therapies in people with common mental disorders. The objective of this study was to estimate a preference-based index for this population using CORE-6D, a health state classification system derived from the CORE-OM consisting of a 5-item emotional component an...
متن کاملMucociliary clearance as an outcome measure for cystic fibrosis clinical research.
Current concepts of cystic fibrosis (CF) pathophysiology link ion transport abnormalities to reduced airway surface liquid (ASL) hydration and impaired mucus clearance. It is likely that correction of the defects that cause ASL dehydration will prevent degradation of mucus clearance, thereby preventing the initiation and/or progression of CF lung disease. A number of novel therapeutic agents ai...
متن کاملDevelopment of a multiple sclerosis functional composite as a clinical trial outcome measure.
The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New therapies appear to favourably impact the course of multiple sclerosis and render continued use of placebo control groups more difficult. Consequently, future trials are likely to compare active treatment groups which will most probably requir...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cystic Fibrosis
سال: 2015
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(15)30129-6